Literature DB >> 29701146

Role of Melatonin in the Inflammatory Process and its Therapeutic Potential.

Livia Carrascal1, Pedro Nunez-Abades1, Antonio Ayala2, Mercedes Cano1.   

Abstract

Melatonin is an indolamine synthesized and secreted by the pineal gland along with other extrapineal sources including immune system cells, the brain, skin and the gastrointestinal tract. Growing interest in this compound as a potential therapeutic agent in several diseases stems from its pleiotropic effects. Thus, melatonin plays a key role in various physiological activities that include regulation of circadian rhythms, immune responses, the oxidative process, apoptosis or mitochondrial homeostasis. Most of these processes are altered during inflammatory pathologies, among which neurodegenerative and bowel diseases stand out. Therapeutic assays with melatonin indicate that it has a beneficial therapeutic value in the treatment of several inflammatory diseases, such as Alzheimer, Amiotrophic Lateral, Multiple Sclerosis and Huntigton´s disease as well as ulcerative colitis. However, contradictory effects have been demonstrated in Parkinson´s and Chron´s diseases, which, in some cases, the reported effects were beneficial while in others the pathology was exacerbated. These various results may be related to several factors. In the first place, it should be taken into account that at the beginning of the inflammation phase there is a production of reactive oxygen species (ROS) that should not be blocked by exclusively antioxidant molecules, since, on the one hand, it would be interfering with the action of neutrophils and macrophages and, on the other, with the apoptotic signals activated by ROS. It is also important to keep in mind that the end result of an anti-inflammatory molecule will depend on the degree of inflammation or whether or not it has been resolved and has therefore become chronic. In this review we present the use of melatonin in the control of inflammation underlying the above mentioned diseases. These actions are mediated through their receptors but also with their direct antioxidant action and melatonin's ability to break the vicious cycle of ROSinflammation. This review is aimed at evaluating the effect of melatonin on activity of the inflammatory process and at its immunomodulator effects. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Melatonin; bowel diseases; immunomodulation; inflammation; neurodegenerative diseases; oxidative stress.

Mesh:

Substances:

Year:  2018        PMID: 29701146     DOI: 10.2174/1381612824666180426112832

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  28 in total

Review 1.  Effects of melatonin on protecting against lung injury (Review).

Authors:  Weiwei Wang; Ju Gao
Journal:  Exp Ther Med       Date:  2021-01-20       Impact factor: 2.447

Review 2.  Melatonin: a pleiotropic hormone as a novel potent therapeutic candidate in arsenic toxicity.

Authors:  Naseh Abdollahzade; Maryam Majidinia; Shirin Babri
Journal:  Mol Biol Rep       Date:  2021-08-28       Impact factor: 2.316

3.  Gut microbiota mediate melatonin signalling in association with type 2 diabetes.

Authors:  Xueran Huang; Yang Qiu; Yongfen Gao; Rong Zhou; Qiantu Hu; Zouyan He; Yingnan Lv; Xi Wang; Wanrong Chen; Yuqing Deng; Zhuangzhuang An; Haiying Zhang; Zengnan Mo; Rui Lin
Journal:  Diabetologia       Date:  2022-06-30       Impact factor: 10.460

Review 4.  SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19.

Authors:  Ana Muñoz-Jurado; Begoña M Escribano; Eduardo Agüera; Javier Caballero-Villarraso; Alberto Galván; Isaac Túnez
Journal:  J Neurol       Date:  2022-07-05       Impact factor: 6.682

Review 5.  A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19.

Authors:  Wen-Lin Su; Chia-Chao Wu; Shu-Fang Vivienne Wu; Mei-Chen Lee; Min-Tser Liao; Kuo-Cheng Lu; Chien-Lin Lu
Journal:  Front Nutr       Date:  2022-06-20

6.  Improved urinary melatonin level as the perspective indicator that leads to better sleeping quality in bladder cancer patients.

Authors:  Tse-Chou Cheng; Yi-Hua Lee; Yuan-Ping Chang; De-Chih Lee
Journal:  Ther Adv Urol       Date:  2020-07-27

Review 7.  The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review.

Authors:  Claudia Pivonello; Mariarosaria Negri; Roberta Patalano; Feliciana Amatrudo; Tatiana Montò; Alessia Liccardi; Chiara Graziadio; Giovanna Muscogiuri; Rosario Pivonello; Annamaria Colao
Journal:  Obes Rev       Date:  2021-12-03       Impact factor: 10.867

Review 8.  Ionizing Radiation as a Source of Oxidative Stress-The Protective Role of Melatonin and Vitamin D.

Authors:  Jarosław Nuszkiewicz; Alina Woźniak; Karolina Szewczyk-Golec
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 9.  Antioxidant Melatonin: Potential Functions in Improving Cerebral Autoregulation After Subarachnoid Hemorrhage.

Authors:  Zhen-Ni Guo; Hang Jin; Huijie Sun; Yingkai Zhao; Jia Liu; Hongyin Ma; Xin Sun; Yi Yang
Journal:  Front Physiol       Date:  2018-08-17       Impact factor: 4.566

Review 10.  Intestinal Ca2+ absorption revisited: A molecular and clinical approach.

Authors:  Vanessa A Areco; Romina Kohan; Germán Talamoni; Nori G Tolosa de Talamoni; María E Peralta López
Journal:  World J Gastroenterol       Date:  2020-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.